No Data
No Data
Sanofi Receives Higher Offer From PAI Partners for Opella After Deadline Lapses
J.P. Morgan Reaffirms Their Hold Rating on Sanofi (SNYNF)
PAI Partners Raises Offer for Sanofi's Consumer Unit - Reports
Response Pharmaceuticals Announces Enrollment of First Patients in a Phase 2 Study Evaluating RDX-002, a Novel Small Molecule IMTP Inhibitor, in Patients Discontinuing GLP-1 Agonists & Clinical Presentation at Obesity Week
UBS Remains a Buy on Sanofi (SNYNF)
Exscientia Advances Two Additional Discovery Programs With Sanofi
No Data
No Data